TREE vs VRTX · P/E 2.8, rev $900.2M vs P/E 30, rev $12.00B
Lendingtree Inc (TREE) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Lendingtree Inc (TREE) is a financial conglomerates company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported TREE revenue for 2024-12-31 was $900.2M. Net income was -$41.7M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
TREE currently screens at market cap $499.8M and trailing P/E 2.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the TREE and VRTX stock pages for the full models.
Not investment advice.